Search

Magdalene K. Sgagias

Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
637
Issued Applications
229
Pending Applications
42
Abandoned Applications
366

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6479572 [patent_doc_number] => 20100041741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS' [patent_app_type] => utility [patent_app_number] => 12/446878 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23855 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041741.pdf [firstpage_image] =>[orig_patent_app_number] => 12446878 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/446878
SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS Oct 18, 2007 Abandoned
Array ( [id] => 102240 [patent_doc_number] => 07723055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Diagnosing and treating hematopoietic cancers' [patent_app_type] => utility [patent_app_number] => 11/874703 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 37 [patent_no_of_words] => 20925 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723055.pdf [firstpage_image] =>[orig_patent_app_number] => 11874703 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/874703
Diagnosing and treating hematopoietic cancers Oct 17, 2007 Issued
Array ( [id] => 5485877 [patent_doc_number] => 20090275642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES' [patent_app_type] => utility [patent_app_number] => 12/311379 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15923 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275642.pdf [firstpage_image] =>[orig_patent_app_number] => 12311379 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/311379
DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES Oct 4, 2007 Abandoned
Array ( [id] => 5428585 [patent_doc_number] => 20090087895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'EXPRESSION VECTORS FOR PRODUCING TAG-CLEAVABLE FUSION PROTEINS IN MULTIPLE EXPRESSION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 11/862900 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5495 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087895.pdf [firstpage_image] =>[orig_patent_app_number] => 11862900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/862900
Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells Sep 26, 2007 Issued
Array ( [id] => 6024213 [patent_doc_number] => 20110052539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'ONCOLYTIC RHABDOVIRUS' [patent_app_type] => utility [patent_app_number] => 12/441494 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052539.pdf [firstpage_image] =>[orig_patent_app_number] => 12441494 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/441494
Oncolytic rhabdovirus Sep 16, 2007 Issued
Array ( [id] => 4765108 [patent_doc_number] => 20080176319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods and compositions for modulating apoptotic pathways' [patent_app_type] => utility [patent_app_number] => 11/901314 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20152 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176319.pdf [firstpage_image] =>[orig_patent_app_number] => 11901314 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/901314
Methods and compositions for modulating apoptotic pathways Sep 16, 2007 Abandoned
Array ( [id] => 4772612 [patent_doc_number] => 20080058271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Prevention of primary sjogren\' s Syndrome by ICA69 deficiency' [patent_app_type] => utility [patent_app_number] => 11/895892 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7872 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058271.pdf [firstpage_image] =>[orig_patent_app_number] => 11895892 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/895892
Prevention of primary sjogren' s Syndrome by ICA69 deficiency Aug 27, 2007 Abandoned
Array ( [id] => 4771922 [patent_doc_number] => 20080057580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of differentiation induction to osteoblasts' [patent_app_type] => utility [patent_app_number] => 11/892061 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10172 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057580.pdf [firstpage_image] =>[orig_patent_app_number] => 11892061 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/892061
Method of differentiation induction to osteoblasts Aug 19, 2007 Issued
Array ( [id] => 6615959 [patent_doc_number] => 20100003224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/375987 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25628 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003224.pdf [firstpage_image] =>[orig_patent_app_number] => 12375987 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375987
Combination Therapy Aug 1, 2007 Abandoned
Array ( [id] => 4939411 [patent_doc_number] => 20080076730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/778900 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18994 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076730.pdf [firstpage_image] =>[orig_patent_app_number] => 11778900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/778900
EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY Jul 16, 2007 Abandoned
Array ( [id] => 6513710 [patent_doc_number] => 20100011450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/373373 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10350 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20100011450.pdf [firstpage_image] =>[orig_patent_app_number] => 12373373 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373373
IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES Jul 12, 2007 Abandoned
Array ( [id] => 5580546 [patent_doc_number] => 20090175892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes' [patent_app_type] => utility [patent_app_number] => 11/826134 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17004 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175892.pdf [firstpage_image] =>[orig_patent_app_number] => 11826134 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/826134
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes Jul 11, 2007 Issued
Array ( [id] => 6475702 [patent_doc_number] => 20100284971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'MODIFIED FACTOR VIII AND FACTOR IX GENES AND VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 12/305508 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 10433 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284971.pdf [firstpage_image] =>[orig_patent_app_number] => 12305508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305508
Modified factor VIII and factor IX genes and vectors for gene therapy Jun 18, 2007 Issued
Array ( [id] => 6009083 [patent_doc_number] => 20110061115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Lung rpogenitor cells, assays, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/308351 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15828 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061115.pdf [firstpage_image] =>[orig_patent_app_number] => 12308351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/308351
Lung epithelial progenitor cells Jun 17, 2007 Issued
Array ( [id] => 4758864 [patent_doc_number] => 20080311090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods for inhibition of proliferative disease, including hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 11/764130 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7865 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311090.pdf [firstpage_image] =>[orig_patent_app_number] => 11764130 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/764130
Methods for inhibition of proliferative disease, including hepatocellular carcinoma Jun 14, 2007 Abandoned
Array ( [id] => 7692180 [patent_doc_number] => 20070231853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 11/758593 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11720 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231853.pdf [firstpage_image] =>[orig_patent_app_number] => 11758593 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/758593
METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS Jun 4, 2007 Abandoned
Array ( [id] => 5125901 [patent_doc_number] => 20070238172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 11/757168 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11720 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238172.pdf [firstpage_image] =>[orig_patent_app_number] => 11757168 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/757168
METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS May 31, 2007 Abandoned
Array ( [id] => 5127964 [patent_doc_number] => 20070240235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS' [patent_app_type] => utility [patent_app_number] => 11/754339 [patent_app_country] => US [patent_app_date] => 2007-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21387 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20070240235.pdf [firstpage_image] =>[orig_patent_app_number] => 11754339 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/754339
METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS May 27, 2007 Abandoned
Array ( [id] => 4546112 [patent_doc_number] => 07960173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Cardiac conduction system cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/753719 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 17494 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960173.pdf [firstpage_image] =>[orig_patent_app_number] => 11753719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/753719
Cardiac conduction system cells and uses thereof May 24, 2007 Issued
Array ( [id] => 4978292 [patent_doc_number] => 20070219526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Restenosis Therapy Using Mesenchymal Stem Cells' [patent_app_type] => utility [patent_app_number] => 11/749522 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5451 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219526.pdf [firstpage_image] =>[orig_patent_app_number] => 11749522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/749522
Restenosis Therapy Using Mesenchymal Stem Cells May 15, 2007 Abandoned
Menu